# AET02SMQ variant 1 is produced correctly

    Code
      res
    Output
                                                                   Xanomeline High Dose   Placebo    Xanomeline Low Dose
                                                                          (N=84)           (N=86)          (N=84)       
      ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one adverse event          11 (13.1%)        4 (4.7%)        5 (6.0%)      
      SMQ01NAM                                                                                                          
        Total number of patients with at least one adverse event        11 (13.1%)        4 (4.7%)        5 (6.0%)      
        Overall total number of events                                      22               6                9         
        VOMITING                                                         7 (8.3%)         3 (3.5%)        3 (3.6%)      
        NAUSEA                                                           6 (7.1%)         3 (3.5%)        3 (3.6%)      

# AET02SMQ variant 2 is produced correctly

    Code
      res
    Output
                                                                   Xanomeline High Dose    Placebo     Xanomeline Low Dose
                                                                          (N=84)            (N=86)           (N=84)       
      ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one adverse event          15 (17.9%)        10 (11.6%)        8 (9.5%)      
      SMQ01NAM                                                                                                            
        Total number of patients with at least one adverse event        11 (13.1%)         4 (4.7%)         5 (6.0%)      
        Overall total number of events                                      22                6                 9         
        VOMITING                                                         7 (8.3%)          3 (3.5%)         3 (3.6%)      
        NAUSEA                                                           6 (7.1%)          3 (3.5%)         3 (3.6%)      
      CQ01NAM                                                                                                             
        Total number of patients with at least one adverse event         6 (7.1%)          7 (8.1%)         3 (3.6%)      
        Overall total number of events                                      9                 8                 4         
        HEADACHE                                                         6 (7.1%)          7 (8.1%)         3 (3.6%)      

